G. Aziz

Procaspase-3 Activating Therapeutic Agents in Cancer Therapy

G. Aziz, 2014 .

Synthesis and initial in vitro biological evaluation of two new zinc-chelating compounds: comparison with TPEN and PAC-1.

R. Paulsen, T. Hansen, P. Rongved, 2013, Bioorganic & medicinal chemistry.

Cell death induced by novel procaspase-3 activators can be reduced by growth factors.

R. Paulsen, G. Aziz, Karen A Boldingh Debernard, 2011, Biochemical and biophysical research communications.

Mechanism of cell death induced by caspase activators PAC-1 and 1541 and tubulin inhibitor combretastatin A-4 : Crosstalk between caspases, ROS and growth factors

G. Aziz, 2011 .

Procaspase-activating compound 1 induces a caspase-3-dependent cell death in cerebellar granule neurons.

R. Paulsen, T. Hansen, G. Aziz, 2010, Toxicology and applied pharmacology.

Combretastatin A-4 and structurally related triazole analogues induce caspase-3 and reactive oxygen species-dependent cell death in PC12 cells.

R. Paulsen, T. Hansen, G. Mathisen, 2013, European journal of pharmacology.

BIOAVAILABILITY OF FAMOTIDINE TABLETS BY USING DIFFERENT COATING MATERIALS

N. Akhtar, A. Ullah, H. Khan, 2007 .